18 results with keyword: 'association systemic lupus erythematosus periodontal disease'
Chorea in systemic lupus erythematosus and ‘lupus-like’ disease: association with anti- phospholipid antibodies. Sem
N/A
SLE: systemic lupus erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; LN: lupus nephritis; ELISA: enzyme-linked immunosorbent assay; CIA:
N/A
SLE, systemic lupus erythematosus; PD, periodontal disease (periodontitis); PPD, probing pocket depth; VPI, visible plaque index; GBI, gingival bleeding index; ABL, alveolar bone
N/A
Abbreviations: RCT: randomised controlled trial; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; SSc: systemic sclerosis; *
N/A
RTA: renal tubular acidosis; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; TTKG: transtubular potassium
N/A
* SLE ⫽ systemic lupus erythematosus; VAS ⫽ visual analog scale; ECLAM ⫽ European Consensus Lupus Activity measurement; SLEDAI ⫽ Systemic Lupus Erythematosus Disease Activity
N/A
lung disease in systemic lupus erythematosus. Semin Arthritis Rheum. Pulmonary manifestations of. systemic lupus erythematosus. Clin Chest Med. Pulmonary involvement in systemic
N/A
(2013) Successful Hematopoietic Cell Transplanta- tion in a Child with Sickle Cell Disease and Systemic Lupus Erythematosus. (2010) The Overlap of Systemic Lupus Erythematosus
N/A
Keywords Lupus, cutaneous (CLE) and systemic lupus erythematosus (SLE), ‘discoid’ lupus erythematosus (DLE), efficacy endpoints, disease activity indices, claims 12... Guideline
N/A
(A) Patients with systemic lupus erythematosus (SLE) with a moderate to severe flare of disease (Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score >10) or
N/A
This registry assessed clinical features, disease activity [Systemic Lupus Erythematosus Disease Activity Index 2000 (SLE- DAI-2K)], and organ damage [Systemic Lupus
N/A
TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, 2012-2018 (%) 8 FIGURE 1 DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS 32 FIGURE 2 PATIENT CARE PATH IN SYSTEMIC LUPUS ERYTHEMATOSUS 35 FIGURE
N/A
4 The average weighted UniFrac distance values (the beta diversities) of healthy subjects (control) and patients with Systemic Lupus Erythematosus (SLE) with chronic periodontitis
N/A
Glomerulonephritis associated with chronic granulomatous disease and systemic lupus erythematosus..
N/A
2 Alpha diversity index, a observed species and b Chao1 index of control subjects or Systemic Lupus Erythematosus patients (SLE) with chronic periodontitis (CP) or Non-CP
N/A
Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. 26] Stafford-Brady FJ, Urowitz MB, Gladman DD,
N/A
† For the Safety of Estrogens in Lupus Erythematosus National As- sessment version of the Systemic Lupus Erythematosus Disease Activity Index (SELENA- SLEDAI) Flare Index
N/A
ANA: Anti-nuclear antibody; SARD: Systemic autoimmune rheumatic disease; SLE: Systemic lupus erythematosus; SjD: Sjogren ’ s disease; SSc: Systemic sclerosis; UCTD:
N/A